Clinical Trials Browser

Completed × Solid Tumor × Trastuzumab × Clear all

NCT03916094 2022-05-05

Evaluate Safety, Tolerability and Pharmacokinetics of HLX22 in Patients With Advanced Solid Tumors Overexpressing HER2

Phase 1 Completed

Other solid neoplasm

Solid Tumor